Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px
Document › Details

Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Presentation by Dr. Michael Hayden at the Jefferies Virtual Conference".

Organisations Organisation Prilenia Therapeutics B.V.
  Group Prilenia (Group)
  Organisation 2 Forbion Capital Partners (NL)
Products Product pridopidine
  Product 2 Jefferies 2020 Virtual Healthcare Conference DIGITAL
Index terms Index term Teva–Prilenia: pridopidine, 201809 establishment of Prilenia with acquisition of pridopidine from Teva
  Index term 2 Prilenia–Leucadia: investor conference, 202006 supply service Prilenia presents at Jefferies 2020 Virtual Healthcare Conference
Persons Person Hayden, Michael R. (Prilenia Therapeutics 202006– CEO former President Global RnD + CSO at Teva)
  Person 2 Mulder, Geert-Jan (Forbion Capital Partner 201509 General Partner before ABN AMRO Capital)
     


   
Record changed: 2020-06-06

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Prilenia (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner Bionnale 2021 Digital Event 650x80px




» top